A detailed history of Great West Life Assurance CO transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 105,711 shares of ARWR stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,711
Previous 102,091 3.55%
Holding current value
$1.93 Million
Previous $2.65 Million 22.78%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.36 - $29.54 $70,083 - $106,934
3,620 Added 3.55%
105,711 $2.05 Million
Q2 2024

Aug 12, 2024

BUY
$21.87 - $28.24 $251,942 - $325,324
11,520 Added 12.72%
102,091 $2.65 Million
Q1 2024

May 13, 2024

BUY
$27.21 - $39.48 $219,448 - $318,406
8,065 Added 9.78%
90,571 $2.59 Million
Q4 2023

Feb 13, 2024

SELL
$21.2 - $31.03 $43,396 - $63,518
-2,047 Reduced 2.42%
82,506 $2.52 Million
Q3 2023

Nov 14, 2023

BUY
$26.2 - $36.08 $186,963 - $257,466
7,136 Added 9.22%
84,553 $2.27 Million
Q2 2023

Aug 10, 2023

SELL
$25.16 - $41.38 $151,060 - $248,445
-6,004 Reduced 7.2%
77,417 $2.77 Million
Q1 2023

May 12, 2023

BUY
$23.68 - $38.51 $291,050 - $473,326
12,291 Added 17.28%
83,421 $2.12 Million
Q4 2022

Feb 10, 2023

BUY
$28.0 - $40.56 $204,484 - $296,209
7,303 Added 11.44%
71,130 $2.88 Million
Q3 2022

Nov 01, 2022

BUY
$29.63 - $48.31 $1.89 Million - $3.08 Million
63,827 New
63,827 $2.11 Million
Q2 2022

Aug 09, 2022

BUY
$27.79 - $50.61 $215,039 - $391,620
7,738 Added 13.54%
64,892 $2.28 Million
Q1 2022

May 12, 2022

BUY
$39.62 - $69.97 $194,098 - $342,783
4,899 Added 9.38%
57,154 $2.7 Million
Q4 2021

Feb 14, 2022

BUY
$58.09 - $82.51 $193,962 - $275,500
3,339 Added 6.83%
52,255 $3.46 Million
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $516,137 - $751,131
8,841 Added 22.06%
48,916 $3.08 Million
Q2 2021

Aug 11, 2021

BUY
$62.15 - $90.32 $14,853 - $21,586
239 Added 0.6%
40,075 $3.32 Million
Q1 2021

May 17, 2021

SELL
$61.35 - $90.47 $193,681 - $285,613
-3,157 Reduced 7.34%
39,836 $2.64 Million
Q4 2020

Feb 16, 2021

SELL
$43.82 - $85.37 $221,597 - $431,716
-5,057 Reduced 10.52%
42,993 $3.3 Million
Q3 2020

Nov 17, 2020

BUY
$33.21 - $51.27 $92,456 - $142,735
2,784 Added 6.15%
48,050 $2.07 Million
Q3 2020

Nov 13, 2020

SELL
$33.21 - $51.27 $341,265 - $526,850
-10,276 Reduced 18.5%
45,266 $1.95 Million
Q2 2020

Aug 17, 2020

BUY
$26.12 - $43.27 $52,866 - $87,578
2,024 Added 3.78%
55,542 $2.4 Million
Q1 2020

May 14, 2020

BUY
$20.56 - $63.12 $115,094 - $353,345
5,598 Added 11.68%
53,518 $1.54 Million
Q4 2019

Feb 11, 2020

BUY
$28.14 - $73.01 $1.35 Million - $3.5 Million
47,920 New
47,920 $3.04 Million
Q3 2019

Oct 25, 2019

SELL
$26.26 - $34.86 $3.35 Million - $4.44 Million
-127,402 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$17.43 - $28.82 $2.02 Million - $3.33 Million
115,704 Added 989.09%
127,402 $0
Q1 2019

May 08, 2019

BUY
$12.05 - $20.18 $47,187 - $79,024
3,916 Added 50.32%
11,698 $214,000
Q2 2018

Aug 10, 2018

BUY
$6.37 - $14.02 $49,571 - $109,103
7,782 New
7,782 $106,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.93B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.